NCT06943508 Nordic Walk on Balance and Functional Strength in Children With Down Syndrome
| NCT ID | NCT06943508 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Down Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2025-04-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2025-04-15 with a primary completion date of 2025-04-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Down syndrome (DS) is one of the more commonly occurring genetic disorders, where mental retardation is combined with nutritional diseases. It is caused by having a third copy of chromosome 21, and there exist 3 forms; Simple Trisomy 21, Translocation Trisomy and Mosaic Trisomy. It is coupled with mental retardation, congenital heart defects, gastrointestinal anomalies .Nordic walking exerts beneficial effects on resting heart rate, blood pressure, exercise capacity, maximal oxygen consumption, and quality of life in patients with various diseases and can thus be recommended to a wide range of people as primary and secondary prevention. This study will aim to examine the effects of Nordic walk on balance and functional strength in children with Down syndrome. A Randomized Controlled Trial will be conducted through convenient sampling 32 subjects will randomly be allocated into two groups. Group A will include 16 children and will receive conventional exercise program. Group B will include 16 children and will receive Nordic walking program. Each session will be 30 minutes, 5 sessions per week. The total duration of the study will be 6 weeks. Pediatric berg balance scale and modified time up and go test, and functional strength test will be used as outcome measure Data will be analyzed on SPSS version 29.0, normality of the data will be checked and tests will be applied according to the normality of the data either it will be parametric test or non-parametric based on the normality.
Eligibility Criteria
Inclusion Criteria: * Children with age group of 8-13 * Both male and female * Functional ability sufficient enough to understand commands, direction and exercise guidance * Have ability to walk 60 meters independently according to 6- minute walk test * Children who can stand and walk with balance problem as revealed from physical examination having 20 to 42 scores on PBS. Exclusion Criteria: Uncontrolled seizures * Any kind of orthopedic condition * Registered visually impaired * Atlanto Axial instability * Any chest infection
Contact & Investigator
Hafiza Namra Khalid, MS-PPT
PRINCIPAL INVESTIGATOR
Study Principal Investigator
Frequently Asked Questions
Who can join the NCT06943508 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 13 Years, studying Down Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06943508 currently recruiting?
Yes, NCT06943508 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06943508 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06943508 clinical trial?
NCT06943508 is sponsored by Riphah International University. The principal investigator is Hafiza Namra Khalid, MS-PPT at Study Principal Investigator. The trial plans to enroll 32 participants.